Global Market for Mobile Apps for DNA Sequencing to Explode (53.8% CAGR)
February 14, 2018 --
WELLESLEY, Mass., Feb. 14, 2018 (GLOBE NEWSWIRE) -- Advancements in genealogy and computational biology are key factors driving unprecedented growth in the global market for mobile applications of DNA sequencing. In a new report, Mobile Apps for DNA Sequencing: Global Markets, BCC Research estimates the overall market to grow from $28.8 billion in 2017 to $248.3 billion by 2022, indicating a compound annual growth rate (CAGR) of 53.8%.
This comprehensive report analyzes mobile applications of DNA sequencing by studying the history, processes and trends used for mapping personal DNA. The analysis, which forecasts the market from 2017 through 2022, discusses important developments, technologies and factors influencing demand. In addition, it examines the increasing affordability of personal genome sequencing worldwide, trends at universities and institutes and trends in healthcare services. The study also provides insight into mobile applications of DNA sequencing, which include technological trends and changes in the approach to personal healthcare.
The National Institutes of Health (NIH) and the National Health Service (NHS) are at the forefront of this developing market. This report addresses worldwide funding and the thought processes behind applying precision medicine to healthcare services. Clinical trials, developing technologies, software and cloud data storage, which are driving the translational science market for future precision medicine in healthcare, are also examined.
- As an end-use segment, genealogy is expected to grow at a 78.2% CAGR through 2022.
- There are more than 60,000 DNA sequencing techniques.
- The market for computational biology is expected to be part of generalized global healthcare by 2022.
“DNA sequencing is a globally developing market that’s being piloted in national healthcare facilities, primarily in the United States and United Kingdom, along with other global resources in the areas of genealogy and computational biology and rare diseases,” said Smruti Munshi, BCC Research analyst and author of the report. “The market is converging between DNA genealogy companies for family searches and computational biology to become one globally similar market in the treatment of healthcare. For example, it’s expected that in two to three years, the market for patients treated through their DNA will be generalized.”
About BCC Research
BCC Research is a publisher of market research reports that provide organizations with intelligence to drive smart business decisions. By partnering with industry experts worldwide, BCC Research provides unbiased measurements and assessments of global markets covering major industrial and technology sectors, including emerging markets. For more information about BCC Research, please visit bccresearch.com. Follow BCC Research on Twitter at @BCCResearch.
CONTACT: Editors/reporters requesting analyst interviews should contact firstname.lastname@example.org.Qualified members of the press can also request permission to access the BCC Research library.